VXRT (VXRT) Stock Price & Analysis
VXRT (VXRT) rose 2.04% to USD 0.5 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
VXRT last closed at USD 0.5; the session ranged USD 0.49–0.51 on volume of 45,659 shares. Market capitalization is —, with a 52-week range of USD 0.31–0.84 (OQX). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 0.5 |
|---|---|
| Change | ▲ 2.04% (up) |
| Previous Close | USD 0.5 |
| Open | USD 0.5 |
| Day Range | USD 0.49 – 0.51 |
| 52-Week Range | USD 0.31 – 0.84 |
| Volume | 45,659 shares |
| Market Cap | — |
| Exchange | OQX |
Technical Analysis (VXRT)
Nexqual's technical model rates VXRT "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 48.12 (neutral) |
| vs SMA50 | Below (USD 0.53) |
| MACD | -0.01 (negative) |
From VXRT's Latest SEC 10-K Filing (filed 2026-03-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INO | Inovio Pharmaceuticals, Inc. | USD 1.43 | ▲ 5.15% |
| SRNE | Sorrento Therapeutics, Inc. | USD 0 | ▲ 0% |
| IBIO | iBio, Inc. | USD 1.31 | ▲ 0% |
| CODX | Co-Diagnostics, Inc. | USD 1.16 | ▲ 0% |
| NVAX | Novavax, Inc. | USD 10.22 | ▼ 0.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.